Nalgesin

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Nalgesin

Property Description
Active ingredient Naproxen Sodium
Form Film-coated tablet
Pharmacological class Nonsteroidal Anti-inflammatory Drug (NSAID)
General purpose Relief from pain, inflammation, and fever
Origin Synthetic (Propionic acid derivative)

Nalgesin is a specific medicinal product defined by its active ingredient, Naproxen Sodium, and is classified as a synthetic agent used for systemic relief from pain and inflammation. This drug entity is manufactured as a film-coated tablet designed for oral use, distinguishing it as a solid dosage form intended to be absorbed into the bloodstream. The entire preparation contains a single active substance, which is utilized for providing symptomatic discomfort relief, aligning with its role as a fundamental treatment.


Nalgesin: Identity and Classification as a Synthetic NSAID

Nalgesin belongs to the broad pharmacological category of Nonsteroidal Anti-inflammatory Drugs (NSAIDs), a class of medication used to manage common inflammatory conditions. Its active component, Naproxen Sodium, is a propionic acid derivative, classifying it among a group of chemically related synthetic compounds. Being the sodium salt of naproxen, the formulation is designed to promote potentially faster absorption than the naproxen base, serving as a distinguishing feature in its systemic delivery. Under the Anatomical Therapeutic Chemical (ATC) classification system, Naproxen is assigned the code M01AE02, identifying it as an anti-inflammatory and antirheumatic agent.

Naproxen Sodium: Core Purpose and Triple Action

The fundamental purpose of Nalgesin is to alleviate symptoms such as pain, inflammation, and fever through a cohesive triple action. This analgesic (pain-relieving), anti-inflammatory, and antipyretic (fever-reducing) effect stems from the drug's mechanism of blocking the synthesis of prostaglandins—which are key biological mediators that generate and intensify these symptoms. The anti-inflammatory effects are established for reducing symptoms of swelling and redness associated with various acute conditions. Consequently, the preparation is generally suited for addressing common symptomatic relief needs, such as managing the discomfort often associated with muscle strain or temporary elevated body temperature.

What side effects are possible with Nalgesin?

Adverse Reaction Profile

Nalgesin, which contains naproxen sodium, is a nonsteroidal anti-inflammatory drug (NSAID) whose safety profile is centrally characterized by the risk of serious gastrointestinal and cardiovascular adverse events. The risk of these serious events is generally considered to be dose- and duration-dependent, increasing with higher doses and prolonged use.

System Organ Class Common Adverse Reactions
Gastrointestinal Disorders Dyspepsia, heartburn, stomach pain, nausea, constipation
Nervous System Disorders Headache, dizziness, drowsiness
Ear and Labyrinth Disorders Tinnitus (ringing in the ears)

Serious Safety Considerations

Regulatory warnings emphasize the risk of serious cardiovascular thrombotic events, including myocardial infarction and stroke, which can be fatal. This risk may occur early in treatment. The drug is contraindicated in the setting of coronary artery bypass graft (CABG) surgery.

Significant gastrointestinal (GI) adverse events include bleeding, ulceration, and perforation of the stomach or intestines, which can occur without warning symptoms and may be fatal, especially in elderly patients. Additionally, the possibility of severe skin reactions (e.g., Stevens-Johnson Syndrome) and anaphylactoid reactions requires immediate cessation if symptoms arise.

Population-Specific Notes

  • Elderly Patients: Have an increased risk of serious adverse reactions, particularly fatal GI bleeding and ulceration, and should use the lowest effective dose for the shortest duration.
  • Pregnancy: Use is generally contraindicated from 30 weeks gestation onward due to the risk of fetal cardiovascular harm. Use in the first and second trimesters should only be considered if strictly necessary.
  • Patients with Impairment: Caution and close monitoring of renal and hepatic function are required in patients with pre-existing kidney, liver, or heart failure, as NSAIDs can cause fluid retention and further organ damage.

Overdose and Emergency Response

Overdose and When to Seek Help

Overdose of Nalgesin (Naproxen Sodium) is officially documented to present with several systemic manifestations. Common signs listed in regulatory sources include gastrointestinal effects such as nausea, vomiting, abdominal pain, and diarrhea. Central Nervous System (CNS) effects may involve drowsiness, severe headache, confusion, dizziness, or agitation. Sensory disturbances like tinnitus (ringing in the ears) are also documented.


Life-Threatening Outcomes and Mandated Action

Regulatory guidance explicitly mandates that individuals seek immediate medical attention or contact a Poison Control Center right away if an overdose is suspected or has occurred. This urgent action is required because massive overdosage can lead to life-threatening outcomes, including gastrointestinal bleeding and perforation, acute renal failure, seizures, and coma.


Management and Population Considerations

No specific antidote is known for acute Naproxen Sodium toxicity, necessitating management through supportive and symptomatic treatment as defined in regulatory protocols. Documented procedural steps include the administration of activated charcoal and continuous monitoring of vital signs. Regulatory information also notes that the risk of severe complications is greater for elderly patients and those with pre-existing kidney or liver disease.

Therapeutic Uses of Nalgesin

What Nalgesin Treats: Main Uses and Benefits

Nalgesin (Naproxen Sodium) is commonly used to help manage pain, inflammation, and fever, offering supportive assistance in addressing symptoms related to inflammatory or irritative states. Its therapeutic scope covers multiple domains, and the medication is relevant for easing symptoms related to physical discomfort and functional strain.

Relief of Pain and Inflammatory Conditions

This medication is commonly applied in clinical settings that involve chronic conditions characterized by periods of heightened symptoms, such as those seen in certain types of arthritis. It may support patients during long-term episodes of joint pain, stiffness, and swelling. It is also commonly used to address acute conditions like gouty arthritis, bursitis, and tendinitis, as well as pain from sprains and strains.

“One key benefit of this medication is its ability to support patients during difficult episodes by easing the overall burden of symptoms that interfere with routine activities.”

Moderating Cyclical and Systemic Discomfort

Nalgesin is applied across domains where additional symptomatic support is needed for recurrent or episodic manifestations, such as primary dysmenorrhea (menstrual cramps) with distressing symptoms and migraine symptoms. It may assist with fever, and supports general well-being during symptomatic phases by contributing to easing the overall symptom load.


Quick Fact: Symptomatic Relief Domains

Nalgesin is generally used to help improve day-to-day comfort during symptomatic periods and may assist with functional stability when pain and stiffness become more noticeable in conditions involving inflammatory or irritative processes.

Eligibility and Restrictions for Use

Nalgesin, which contains the active substance naproxen sodium, is generally used by adults and adolescents typically aged 12 years and older for the short-term relief of mild to moderate pain, such as headache, toothache, muscular pain, or menstrual pain.


Contraindications (Who Should Not Use)

Nalgesin is not suitable for everyone. Do not use this medication if you:

  • Have a known allergy or hypersensitivity to naproxen sodium, naproxen, or any other non-steroidal anti-inflammatory drug (NSAID) like aspirin or ibuprofen.
  • Have a history of asthma, hives (urticaria), or allergic-type reactions after taking aspirin or other NSAIDs.
  • Have active or recurrent gastrointestinal ulcers, bleeding, or perforation.
  • Have severe heart, liver, or kidney failure.
  • Are in the last three months of pregnancy.
  • Are undergoing or have recently undergone coronary artery bypass graft (CABG) surgery.

Special Caution (Consult a Healthcare Professional)

Consult your doctor before use if you have a history of conditions like heart disease, high blood pressure (hypertension), diabetes, high cholesterol, or a history of stroke. Caution is also advised for the elderly, individuals with existing gastrointestinal issues, and those taking certain medications, including blood thinners, corticosteroids, or other NSAIDs.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory information for Naproxen Sodium establishes constraints for use with numerous co-administered products, primarily concerning effects on clearance and additive risks.

Classification of Interaction
Formal Contraindication Use is contraindicated for the treatment of perioperative pain in the setting of Coronary Artery Bypass Graft (CABG) surgery. Concomitant use with other Nonsteroidal Anti-inflammatory Drugs (NSAIDs) or analgesic doses of Aspirin is generally not recommended due to increased risk.
Exposure Modification Co-administration with Lithium and Digoxin can increase their plasma concentrations due to reduced renal clearance. Methotrexate toxicity may be enhanced as Naproxen reduces its tubular secretion. Probenecid is known to increase Naproxen plasma levels and extend its half-life.
Pharmacodynamic Effects The medication may diminish the therapeutic effect of Antihypertensives (e.g., ACE-Inhibitors, ARBs) and Diuretics. It can enhance the effects of Anticoagulants (e.g., Warfarin) and is associated with an increased risk of bleeding when taken with Antiplatelet Agents or Corticosteroids.
Timing and Substance Rules NSAIDs should not be used for 8–12 days following Mifepristone administration. Consumption of three or more alcoholic drinks daily is officially documented to increase the risk of severe gastrointestinal bleeding.

These constraints define the product’s interaction profile, requiring caution where a formal reduction in efficacy, an elevated risk of organ toxicity, or a specific timing separation window is documented in government regulatory labeling.

Mechanism of Action

The mechanism of action for Naproxen Sodium (Nalgesin) is defined by its targeted interference with specific enzyme systems and signaling pathways, which subsequently influences core regulatory physiology. The drug's effect profile is a direct result of these mechanistic adjustments.

Molecular Targeting of Cyclooxygenase (COX) Enzymes

The primary mechanism involves the reversible competitive inhibition of the COX-1 and COX-2 enzymes, which are necessary for the conversion of arachidonic acid into prostaglandins. This enzymatic blockade fundamentally suppresses the entire prostaglandin synthesis pathway, a critical biological process involved in sensitizing peripheral nociceptors and elevating the hypothalamic thermal set point.

Modulation of Systemic Signaling Cascades

By drastically reducing prostaglandin levels, the drug modifies critical downstream signaling events in the body. This action limits the excessive chemical amplification of pain signals in the periphery by desensitizing nerve endings, and concurrently, it acts centrally within the hypothalamus to adjust the thermal set point, resulting in the adjustment of the hypothalamic thermal set point.

⏱️ Mechanism-Dependent Onset Factor

The drug's formulation as a sodium salt directly relates to the speed of its mechanistic action. This salt form accelerates the drug’s physical dissolution and absorption rate, ensuring that the necessary inhibitory concentration ( IC50) to engage the COX-2 target is reached more rapidly than with the free acid form, thereby influencing the speed at which the physiological effect begins.

Dosage and Administration Information

The use of Nalgesin (Naproxen Sodium) involves standard parameters regarding its administration route, dosage schedules, and procedural adherence. The medication is an oral formulation; therefore, proper use involves swallowing the film-coated tablet as directed by a healthcare professional.

Instruction Map: How to use Nalgesin — Administration Guidelines

Component Instruction
Route of administration Oral ingestion.
Dosing schedule Maintenance is typically 550 mg to 1100 mg total daily dose. Acute treatments require an initial loading dose, with the maximum maintenance dose generally set at 1100 mg per day.
Timing/Preparation Must be swallowed with a full glass of water. May be taken with food, milk, or antacids if necessary to enhance gastrointestinal tolerance.
Age-group rules Older adults require consideration of a lower initial dose. Pediatric dosing for Juvenile Idiopathic Arthritis is 10 mg/kg/day in two divided doses.

Instruction Classifications (High-Level)

Administration is classified as Systemic, Oral, with a Twice daily frequency pattern for chronic use. The overarching use-context constraint is the application of the lowest effective dose for the shortest duration necessary. Furthermore, patients with severe renal impairment (creatinine clearance less than 30 mL/min) are generally not recommended to use this drug.


Resulting Procedural Structure

Standard procedures involve a sequence starting with the immediate-release tablet dose being swallowed with a full glass of water. This is followed by adherence to the specific divided-dose schedule set for either short-term (acute) or long-term (chronic) regimens, ensuring the dose remains within established limits and is modified according to the patient's age or organ function status.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Nalgesin


Research Evidence for Pain and Symptomatic Relief in Inflammatory Conditions

The research record for symptoms related to conditions such as Rheumatoid Arthritis (RA) and Osteoarthritis (OA), and other outcomes, primarily comprises Randomized Controlled Trials (RCTs), as well as systematic reviews and regulatory evaluations. These studies were used in research exploring how symptoms change over time in adults diagnosed with these conditions. For conditions marked by functional limitations like OA, patient-reported outcomes describing perceived discomfort and movement ability were key axes that researchers monitored.

In studies conducted during periods of increased symptom activity, studies monitored patient scores for outcomes related to physical discomfort and joint stiffness. Studies report how symptoms evolved in the observed populations, with measurements taken for overall joint function. The existing evidence base primarily characterizes outcomes related to short-term physical discomfort, as the research focus was on symptom patterns rather than long-term disease modification outcomes. While some longer-term observational studies exist, follow-up durations were limited in the initial controlled trials.


Studies on Acute Pain and Inflammatory Episodes

The clinical evaluation for studying symptoms related to acute, temporary conditions, such as Acute Gouty Arthritis and general Acute Musculoskeletal Disorders (like sprains and strains), relied mainly on short-term RCTs and pooled analyses. These studies focused on episodes where symptoms become more noticeable, such as sudden pain or swelling following an injury or a gout flare-up. Research explored short-term symptom changes, with outcomes describing episodic or acute changes being monitored closely.

In these acute research scenarios, research describes measured changes in patient-reported pain scores over the defined time interval compared to baseline or a control group. Studies monitored patient symptoms linked to inflammatory or irritative states and localized tenderness. The evidence remains limited in its generalizability to all acute pain scenarios, as results apply only to the specific injury models and populations studied.


Evidence in Specific Patient Populations and Uncertainty

Research has explored the use of Naproxen Sodium in certain defined groups, with specific consideration given to older adults. Available data show patterns related to how older adults process the drug, which may result in different measured outcomes compared to younger adults. However, Data for certain groups remain insufficient.

One of the main research limitation frames is that comparative evidence is lacking for many one-to-one comparisons against every other nonsteroidal anti-inflammatory drug. Research has explored short-term changes, but the long-term effects are not fully established regarding intermittent use for acute conditions over many years. The study results reflect the specific conditions under which they were conducted, and continued research is ongoing to further explore symptom patterns and functional outcomes.

Key Studies & References

  1. Naproxen in rheumatoid arthritis. A controlled trial (1975)
  2. Geriatric Patients section from NAPROXEN tablet NAPROXEN SODIUM tablet (DailyMed - NIH)

Frequently Asked Questions (FAQ)

Common questions about Nalgesin (FAQ)


Q: How quickly should I expect Nalgesin to start working?

A: Official information indicates that pain relief from naproxen sodium formulations can begin within 30 minutes of administration. The drug’s composition as a sodium salt allows for potentially faster dissolution and absorption, with the highest concentration typically reached in the bloodstream within one to two hours.


Q: How long does the pain relief from Nalgesin last?

A: The duration of the drug’s effects relates to how quickly the body processes and removes it, a measure known as the elimination half-life. According to regulatory sources, this half-life is reported to be between 12 and 17 hours. This characteristic aligns with general dosing instructions found in product information, which often involve administration every 8 to 12 hours.


Q: Is Nalgesin safe for older adults (seniors)?

A: Official documentation notes that older adults may be more sensitive to the effects of this medicine. They also face a potentially greater risk of serious side effects, particularly gastrointestinal bleeding. For this reason, official use is cautioned, and the lowest effective dose for the shortest duration is generally advised for this population.


Q: Is there a difference between the regular Nalgesin tablet and the 'forte' version?

A: Nalgesin is manufactured in different dose strengths (e.g., 275 mg and 550 mg naproxen sodium tablets) which are often labeled differently, such as 'Forte' for a higher strength. The difference relates to the quantity of the active ingredient, with higher strengths providing increased analgesic or anti-inflammatory effect that may be used when higher concentrations are required.


Q: Is Nalgesin safe for teenagers or children?

A: Non-prescription use of naproxen sodium is generally directed toward adults and adolescents aged 12 years and older. Official pediatric dosing is established for certain specific conditions, such as Juvenile Idiopathic Arthritis, but non-prescription use is typically not advised for children younger than 12 years of age.


Q: What is the longest period of time Nalgesin is described as being safe to use continuously?

A: Official instructions consistently emphasize using the medication for the shortest duration necessary to meet treatment goals. While chronic use is recognized for certain conditions, higher doses are generally reserved for limited periods, such as up to six months, and only when the therapeutic benefit clearly outweighs the potential increase in risk.


Q: What is the official information regarding Nalgesin and pregnancy?

A: Official regulatory warnings state that the drug is contraindicated from 30 weeks gestation (the start of the third trimester) onward due to the risk of fetal cardiovascular harm. Use during the first and second trimesters is typically advised only if the potential benefit to the mother is considered to outweigh the potential risks to the developing fetus.


Q: Why is it important to use the lowest effective dose of Nalgesin?

A: Official warnings require the use of the lowest effective dose for the shortest duration necessary to reduce the potential for serious adverse events. Regulatory sources clarify that the risks of serious cardiovascular problems and gastrointestinal bleeding are generally considered to be dose- and duration-dependent.


Q: Is Nalgesin the same thing as Aleve or Naproxen?

A: Nalgesin and Aleve are different brand names for products containing the active ingredient naproxen sodium. Naproxen sodium is the sodium salt formulation of naproxen. This sodium salt is designed to be potentially absorbed more rapidly by the body than the naproxen base formulation.


Q: Can Nalgesin be used for migraine headaches?

A: Official indications list the medication for the relief of mild to moderate pain, including pain associated with conditions such as primary dysmenorrhea. The drug has been explored in a research context for use in certain types of headaches. For severe or persistent headaches, consulting a healthcare provider for appropriate therapy is part of standard medical guidance.


Q: Are there any documented interactions between Nalgesin and herbal supplements?

A: Official drug labels provide comprehensive information on interactions with numerous prescription and over-the-counter medicines. However, governmental health bodies often note that insufficient clinical information is available to confirm the safety of using many specific herbal remedies or complementary medicines alongside this drug.


Q: Is it necessary to drink a full glass of water when taking Nalgesin?

A: Official administration instructions typically state that the tablet must be swallowed with a full glass of water. This is a procedural measure intended to ensure proper swallowing and transit of the tablet through the esophagus to the stomach, which is important for drug absorption.


Q: Can Nalgesin be crushed or split to make it easier to swallow?

A: Nalgesin is manufactured as a film-coated tablet. Unless the tablet is specifically scored, regulatory product information generally indicates that crushing or splitting should be avoided. Regulatory documents suggest that altering the tablet may affect the drug’s intended absorption properties or potentially increase the risk of gastrointestinal irritation.


Q: What is the chemical difference between naproxen and naproxen sodium?

A: The chemical difference is that naproxen sodium is the sodium salt of the active ingredient naproxen. This salt form is designed to be more water-soluble. According to regulatory sources, this increased solubility results in the drug being absorbed more rapidly from the gastrointestinal tract than the naproxen base formulation.


Q: What should I do if I experience ringing in my ears (tinnitus) while on Nalgesin?

A: Ringing in the ears, known as tinnitus, is listed in official documents as a possible adverse reaction to this medication. If this symptom occurs, official safety information indicates that patients should seek guidance from a healthcare professional, as changes in hearing may be a sign of toxicity.


Q: Are there any official reports on Nalgesin affecting mood or mental clarity?

A: Official adverse event lists include central nervous system effects such as dizziness and drowsiness as common reactions. Some official documents also reference possible, though less common, effects on mental or mood status.


Q: Is Nalgesin used for period pain (menstrual cramps)?

A: Yes, official regulatory documents list the management of primary dysmenorrhea, which is the medical term for menstrual cramps, as an established indication for the use of naproxen sodium.


Q: What are the official recommendations for using Nalgesin after dental procedures?

A: Clinical guidance for acute dental pain management, referenced by government health organizations, identifies non-opioid medications, including naproxen, as a primary choice for managing pain following common procedures such as tooth extractions.


Q: Does the efficacy of Nalgesin differ based on the type of inflammation?

A: The drug is officially indicated for symptoms related to specific inflammatory conditions like Rheumatoid Arthritis, Osteoarthritis, and Acute Gouty Arthritis. While research evidence is established for these conditions, official product documents do not distinguish efficacy based on subtle or molecular 'types' of inflammation.

How should Nalgesin be stored and disposed of?

How to Store and Dispose of Nalgesin

Nalgesin (Naproxen Sodium) must be stored and disposed of according to the specific instructions provided in the official regulatory labeling to ensure product stability and safety.

Storage Requirements

The tablets are required to be stored at Controlled Room Temperature, which is typically defined as 20 C to 25 C (68 F to 77 F). Storage conditions must protect the medicine from light, excessive heat (above 40 C), and high humidity. The medicine must be kept in its original container and out of the sight and reach of children.

Disposal Instructions

Expired or unused Nalgesin must not be disposed of in the household trash or down the drain to avoid environmental contamination. Disposal is required to follow local pharmaceutical waste regulations.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Nalgesin found in:

A-Z Index: